Premium
Clinical Pharmacokinetics of Vemurafenib in BRAF‐Mutated Melanoma Patients
Author(s) -
Nijenhuis C. M.,
Huitema A. D. R.,
Blank C.,
Haanen J. B. A. G.,
Thienen J. V.,
Rosing H.,
Schellens J. H. M.,
Beijnen J. H.
Publication year - 2017
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.788
Subject(s) - vemurafenib , medicine , clinical pharmacology , pharmacy , cancer , clinical oncology , oncology , family medicine , pharmacology , metastatic melanoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom